Q4 2016

Latest Quarterly Results
Ended June 30, 2016

$806,578

Research and development YTD

$2,205,144

Net cash used in operations YTD

Profile

Business Description

Propanc is currently focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. We have developed a formulation of anti-cancer compounds which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Our products involve or employ proenzymes, which are inactive precursors of enzymes.

Company Info

Address:
302/6 Butler Street
Camberwell, VIC 3124

Telephone:
+613-9882-6723

Email:
info@propanc.com

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
Pharmaceutical Preparation Manufacturing (325412)

SIC:
Pharmaceutical Preparations (2834)

Sign up for email alerts

Be the first to receive breaking news

Sign up today